DCOY
Decoy Therapeutics Inc.
NASDAQ: DCOY · HEALTHCARE · BIOTECHNOLOGY
$5.54
+1.19% today
Updated 2026-04-29
Market cap
$2.89M
P/E ratio
—
P/S ratio
15.86x
EPS (TTM)
$-129.10
Dividend yield
—
52W range
$5 – $239
Volume
0.1M
Decoy Therapeutics Inc. (DCOY) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-338.30%
ROA
-36.40%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2014 | — | $-8.01M | — | — | — |
| 2015 | — | $-29.14M | — | — | — |
| 2016 | $1.01M | $-39.49M | 34.42% | -3,946.54% | -3,907.65% |
| 2017 | $1.27M | $-34.43M | 60.26% | -2,724.65% | -2,701.74% |
| 2018 | $838142.00 | $-21.92M | 48.61% | -2,633.71% | -2,615.57% |
| 2019 | $3.47M | $-6.94M | 100.00% | -238.53% | -200.18% |
| 2020 | $5.23M | $-7.35M | 100.00% | -148.78% | -140.49% |
| 2021 | $1.84M | $-12.77M | 98.96% | -696.27% | -693.84% |
| 2022 | $0.00 | $-31.61M | — | — | — |
| 2023 | $0.00 | $-12.54M | — | — | — |
| 2024 | $0.00 | $-5.58M | — | — | — |
| 2025 | $0.00 | $-12.52M | — | — | — |